Vasopressin deficiency in the syndrome of irreversible shock

Journal of Trauma - Injury, Infection and Critical Care

Volumn 54, Issue 5 SUPPL., 2003, Pages

  Robin, Jennie K ^b   Oliver, Juan A ^b   Landry, Donald W ^a  

^a Bldg 10 445 ^*  (United States)

^b NONE

Author keywords

Adenosine triphosphate gated potassium channel; Nitric oxide; Sepsis; Shock; Vasopressin

Indexed keywords

ARGIPRESSIN; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ARTERIAL PRESSURE; CARDIOGENIC SHOCK; CONFERENCE PAPER; HEMORRHAGIC SHOCK; HORMONE DEFICIENCY; HORMONE SENSITIVITY; HUMAN; HYPONATREMIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEPTIC SHOCK; SHOCK; SIDE EFFECT; SMOOTH MUSCLE TONE; SYNDROME; VASCULAR SMOOTH MUSCLE; VASODILATATION; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HUMANS; MUSCLE, SMOOTH, VASCULAR; SHOCK; SYNDROME; VASOCONSTRICTOR AGENTS; VASODILATION; VASOPRESSINS;

EID: 0038001553     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest. 1992;89:2071-2074.
2. Sylvester JT, Scharf SM, Gilbert RD, Fitzgerald RS, Traystman RJ. Hypoxic and CO hypoxic in dogs: hemodynamics, carotid reflexes, and catecholamines. Am J Physiol. 1979;236:22-28.
3. Remington JW, Hamilton WF, Caddell HM, et al. Some circulatory responses to hemorrhage in the dog. Am J Physiol. 1950;161:106-115.
4. Rutherford RB, Trow RS. The pathophysiology of irreversible hemorrhagic shock in monkeys. J Surg Res. 1973;14:538-550.
5. Thiemermann C, Szabo C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA. 1993;90:267-271.
6. Argenziano M, Choudhri AF, Oz MC, et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation. 1997;96(suppl II):II-286-II-290.
7. Kristof AS, Magder S. Low systemic vascular resistance in patients undergoing cardiopulmonary bypass. Crit Care Med 1999;27:1121-1127.
8. Bocka JJ, Overtone DH, Hauser A. Electromechanical dissociation in human beings: an echocardiographic evaluation. Ann Emerg Med. 1988;7:450-452.
9. +-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol. 1992;263:491-496.
10. Errington ML, Rocha a Silva M Jr. Vasopressin clearance and secretion during hemorrhage in normal dogs and in dogs with experimental diabetes insipidus. J Physiol. 1972;327:395-418.
11. Zerbe RL, Feurstein G, Kopin IJ. Effect of captopril on cardiovascular, sympathetic and vasopressin responses to hemorrhage. Eur J Pharmacol. 1981;72:391-395.
12. Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation. 1999;100:226-229.
13. Jackson WF. Ion channels and vascular tone. Hypertension. 2000; 35:173-178.
14. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev. 1997; 77:1166-1232.
15. Archer SL, Huang JMC, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA. 1994;91:7583-7587.
16. Bolotina VM, Najlbi S, Paacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
17. Murphy ME, Brayden JE. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol. 1995;486:47-58.
18. Frajewicki V, Kahana L, Yechieli H, Brod V, Kohan R, Bitterman H. Effects of severe hemorrhage on plasma ANP and glomerular ANP receptors. Am J Physiol. 1997;42:1623-1630.
19. Schneider F, Lutun PH, Couchot A, Bilbault P, Tempe JD. Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med. 1993;19:99-104.
20. Arnalich F, Hernanz A, Jimenez M, et al. Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock. Regul Pept. 1996;65:115-121.
21. Martin C, Leone M, Viviand X, et al. High adenosine plasma concentrations as a prognostic index for outcome in patients with septic shock. Crit Care Med. 2000;28:198-202.
22. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991;214:621-626.
23. Hollenberg SM, Cunnion RE, Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol. 1993;264:660-663.
24. Hollenberg SM, Piotrowski MJ, Parrillo JE. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol. 1997;272:969-974.
25. Zerbe RL, Henry DP, Robertson GL. Vasopressin response to orthostatic hypotension. Am J Med. 1983;74:265-271.
26. Kaufmann H, Oribe E, Oliver JA. Plasma endothelin during upright tilt: relevance for orthostatic hypotension? Lancet. 1991;338:1542-1545.
27. Arnauld E, Czernichow P, Fumoux F, Vincent J-D. The effects of hypotension and hypovolemia in the liberation of vasopressin during hemorrhage in the unanaesthetized monkey. Pflugers Arch. 1977; 371:193-200.
28. Landry DW, Levin HR, Oliver JA, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997; 95:1122-1125.
29. Padfield PL, Brown JJ, Lever AF, Morton JJ, Robertson JIS. Blood pressure in acute and chronic vasopressin excess. N Engl J Med. 1981;304:1067-1070.
30. 1 receptor in cultured rat mesangial cells. Am J Physiol. 1999;276:433-441.
31. Nambi P, Whitman M, Gessner G, Aiyar N, Crooke ST. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle line. Proc Natl Acad Sci USA. 1986;83:8492-8495.